NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) Stock Price, Quote, News & History

Key Statistics

Open

$0.95

Volume / Avg.

0 / 4.27K

Day Range

- - -

52 Wk Range

0.84 - 3.23

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Nuo Therapeutics Inc News

Container Store Group And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones closed lower by around 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

4 Stocks Under $3 Insiders Are Aggressively Buying

Gold futures traded slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.65M

Investing Cash Flow (TTM)

-45.72K

Financing Cash Flow (TTM)

1.90M

Free Cash Flow (TTM)

-1.70M

Capital Expenditure (TTM)

-45.72K

Net Change in Cash (TTM)

208.17K

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$46.83M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

10.96

PB Ratio (TTM)

Earnings Yield % (TTM)

-4.21%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.03

Company Debt

Total Debt

$1.02M

LT Debt

$1.02M

LT Debt Issuance (TTM)

$1.00M

LT Debt Repayment (TTM)

Total Cash

$263.83K

Debt to Equity

Issuance of Debt (TTM)

$1.00M

Repayment of Debt (TTM)

Key Statistics

Open

$0.95

Volume / Avg.

0 / 4.27K

Day Range

- - -

52 Wk Range

0.84 - 3.23

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

N/A

Industry

N/A

Nuo Therapeutics Inc is a commercial-stage medical device company engaged in developing and marketing products for chronic wound care. The company operates as a single segment focused on regenerative therapies that utilize autologous (patient-derived...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) stock?

You can purchase shares of NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB:AURX) through any online brokerage.

View our list of the best stock brokerages

Who are NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) competitors?

There are no as such competitors for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

What is the forecast, or price target, for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) stock?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. has a consensus price target of $3.00.

What is the current price for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX)?

The stock price for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB: AURX) is $0.95 last updated July 20, 2026 at 3:41 PM EDT.

Does NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) pay a dividend?

There are no upcoming dividends for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

When is NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (OTCQB:AURX) reporting earnings?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. does not have any upcoming earnings scheduled.

Is NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) going to split?

There is no upcoming split for NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc..

What sector and industry does NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. (AURX) operate in?

NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc. is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.